Skip to main content
. 2021 Feb 12;5(4):985–993. doi: 10.1182/bloodadvances.2020003654

Table 2.

Results of multivariate analysis adjusted for propensity score

Outcome HR (95% CI) P
Grade 2-4 acute GVHD
 HLA-matched unrelated 1.00
 HLA-haploidentical relative 0.44 (0.31-0.62) <.0001
Grade 3-4 acute GVHD
 HLA-matched unrelated 1.00
 HLA-haploidentical relative 0.26 (0.14-0.48) <.0001
Chronic GVHD
 HLA-matched unrelated 1.00
 HLA-haploidentical relative 0.36 (0.25-0.53) <.0001
NRM*
 HLA-matched unrelated 1.00
 HLA-haploidentical relative 0.90 (0.62-1.31) .57
Relapse
 HLA-matched unrelated 1.00
 HLA-haploidentical relative 1.56 (1.14-2.14) .0055
DFS
 HLA-matched unrelated 1.00
 HLA-haploidentical relative 1.29 (1.01-1.65) .042
OS§
 HLA-matched unrelated 1.00
 HLA-haploidentical relative 0.94 (0.71-1.24) .65

Each patient was assigned a propensity score based on age, KPS, HMAs before transplantation and IPSS-R score at transplantation.

HR, hazard ratio.

*

Adjusted for recipient CMV serostatus.

Adjusted for recipient sex.

Adjusted for donor-recipient sex match.

§

Adjusted for HCT-CI score.